Navigation Links
Medonic 620 Hematology Analyzer Series

ProductsMedonic 620 Hematology Analyzer Series
Company CDS (Clinical Diagnostic Solutions, Inc.)
Item Medonic 620 Hematology Analyzer Series
Features 
  • Open or Closed Vial Sampling
  • 16 Parameters, 3-Part Differential
  • Floating discriminators
  • Direct Micro Sampling MPA
  • Impedance volume and time measuring principle
  • Self cleaning apertures
  • Two reagents system
  • Reliable
  • Minimal maintenance
Description The Clinical Diagnostic Solutions Medonic 620 3-Part Differential; 16-Parameter Hematology instrument series is designed for fast, reliable and accurate patient outcomes with operator ease. On board features include; open and closed vial sampling modules, bar coding to ensure positive patient identification with the ability to enter calibrator and control values automatically, patented micro sample technology for performing finger-stick draws without the need for micro dilution vessels, floating discriminators that reduce the need for manual intervention, self cleaning apertures that help to maintain sample integrity and virtually no daily or weekly maintenance that will reduce time and cost.

Each analyzer is equipped with an expanded quality control module that allows the laboratory to maintain accurate data records with graphics. Interfacing to your LIS is easy through a standard format. The small foot print of the instrument and printer are definite space savers. This instrument series will ensure excellent patient out comes effectively and efficiently.

Info CDS (Clinical Diagnostic Solutions, Inc.)
Customer Service: (800) 453-3328
Web site: http://www.cdsolinc.com/

Related medicine products :

1. Coulter LH 755 Hematology Workcell
2. Coulter LH 750 Hematology Analyzer
3. COULTER LH 755 Hematology Workcell
4. COULTER LH 750 Hematology Analyzer
5. COULTER MAXM Hematology Analyzer
6. COULTER HmX Hematology Analyzer
7. Sysmex XE-2100™ Automated Hematology Analyzer
8. ADVIA 60 Hematology System
9. ADVIA 70 Hematology System
10. ADVIA 120 Hematology System
11. Aerospray Hematology Slide Stainer/Cytocentrifuge
CenterPointLock Drainable Mini-Pouch, White
CenterPointLock Cut-to-Fit SoftFlex Skin Barrier, Flat
CenterPointLock Closed Pouch, White
Inquire
Medicine Products:
(Date:12/1/2008)...ec. 1 Zimmer Holdings, I... Jeffery A. McCaulley has joined the,Company as P...ponsibility for,the Company,s activities in the r...rketing and Americas Sales. Mr. McCaulley will re...nd Chief Executive Officer. , "Jeff has a t...
(Date:12/1/2008)...ase Will Appear in Upcoming TV Commercial - , ...Whitening Expressions is "FanTaste-ic!" Crest Whit...se hosted the "What,s Your Catch Phrase?" conte...res the flavor experience of Crest Whitening Expre...was selected from over 600 contest entries, and Am...
(Date:12/1/2008)...D, Calif., Dec. 1 Transcept Pharma...aceutical company, announced today that,Glenn A. ... is scheduled to,participate at the RBC Capital M...y on a panel entitled "Delivering Novel Drug Solut...ation is scheduled to take place on Thursday, Dece...
(Date:12/1/2008)...., Dec. 1 What do poetry, art, lit... practice? "Everything," according to,Richard S. ...Medical Center,who has pioneered an innovative p...idents in internal medicine. , "Studying th...ne,",explains Dr. Panush, who is a leader among a...
Breaking Medicine News(10 mins):Health News:Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive 2Health News:Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive 3Health News:Video: America Votes Crest Whitening Expressions Is FanTaste-ic! 2Health News:Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel 2Health News:Saint Barnabas Medical Center Pioneers New Program Bringing Humanities and Humanism to Medicine 2Health News:Saint Barnabas Medical Center Pioneers New Program Bringing Humanities and Humanism to Medicine 3Health News:Saint Barnabas Medical Center Pioneers New Program Bringing Humanities and Humanism to Medicine 4
...to stop admitting patients to the Altrincham Gener...cision been taken by NHS managers// who had gather...ient safety is believed to be responsible for the ...hat cash factor is the sole reason. The rehabilita...
...ernational Women’s Day celebrations, an exclusive ...sed Apollo hospitals. Ms. J. Jayalalitha, State Ch...re center on Wednesday. // The health care center...lems of the women folk including sub-acute and chr...
...s that breastfeeding is the best form of nutrition...eding or the weaning age affect the risk of obesit...atforms. // A new study on this aspect has found t...ated to being breastfed or the age in infancy when...
...fessor of psychology and a team of Cornell Univers...nt areas of the brain react differently when recog...tions attached to the memory. The researchers did ...ers. They allowed these hamsters to have social en...
Other Medicine News:Health News:Want to save the child from obesity introduce infant food early: says a study 2Health News:Cure For Autism Could Be Established Through Hamster Studies 2
(Date:12/1/2008)...FirstCall/ -- GeoVax Labs, Inc.,(OTC Bulletin Boa...developing,human vaccines for diseases caused by ...fectious agents, announced today that the launch o...ce in twelve sites across North and South America.... The National Institutes of,Health (NIH), and the...
(Date:11/28/2008)...swire-FirstCall/ -- Eli Lilly and Company,(NYSE: ...plication (sNDA) from,the U.S. Food and Drug Admi...,for the management of chronic pain. Lilly plans t...009, adding data from a recently completed positiv...e. , The decision does not affect duloxetin...
(Date:11/25/2008)...e recovery , , Audio and Web Video Resource...o Clinic News Blog. Please see the bottom of this ...nn., Nov. 25 A Mayo Cli...t think they,re having a stroke -- and as a result...worsens. The findings appear in the current issue ...
(Date:11/25/2008)...PRNewswire-FirstCall/ -- Pharmacyclics, Inc.,(Nas... completed a Phase 1,clinical trial with PCI-2748...cule Factor VIIa inhibitor. The trial was conducte...the safety and pharmacologic effect of,PCI-27483....a linear dose,response in the International Norma...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Gene variant linked to moderated symptoms of beta thalassemia 10535 1Gene variant linked to moderated symptoms of beta thalassemia 10535 2African seed collection first to arrive in Norway on route to Arctic seed vault 10531 1African seed collection first to arrive in Norway on route to Arctic seed vault 10531 2African seed collection first to arrive in Norway on route to Arctic seed vault 10531 3Accelerated head growth can predict autism before behavioral symptoms start 10527 1Accelerated head growth can predict autism before behavioral symptoms start 10527 2Hutchinson Center Announces First Unclimbed Mountain to be Tackled by Big Expedition for Cancer Research 10523 1Hutchinson Center Announces First Unclimbed Mountain to be Tackled by Big Expedition for Cancer Research 10523 2